Subthalamic Nucleus, Akinesia and Parkinson's Disease
RecruitingNCT01682668Phase: NAStarted 2013-02
Summary
This program aims to understand the role of the subthalamic nucleus in the control of the movement in healthy humans and patients with Parkinson's disease, how the STN dysfunction contributes to akine
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
70 Years
Locations
CIC-GHPSParis, France
Groupe Hospitalier Pitie-SalpêtrièreParis, France
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT01682668